IOM sends positive omega-3 DRI signals

By Shane Starling

- Last updated on GMT

Related tags: Nutrition

Adam Ismail, the executive director of the Global Organization for EPA and DHA Omega-3s (GOED) caught up with Shane Starling recently to talk through all things omega-3 (except Proposition 65 and the Whole Foods krill ban which could not be discussed to due to ongoing negotiations).

The good news, he says, is that the Institute of Medicine (IOM) has suggested omega-3s will be the next nutrient to go under the dietary reference intake (DRI) microscope after it is finished with vitamin D and calcium.

The bad news is that the Food and Drug Administration appears set to scrap the omega-3 content claim, ironically enough in part because of a lack of an established DRI.

Ismail said if the omega-3 content claim does go, the IOM work will be go along way to any reinstatement that may occur at a later date.

“The science was only reviewed through 2000 and we think it is the right time to revisit this now because the body of science on EPA and DHA levels has more than doubled in that time,” ​Ismail said.

Ismail notes how a DRI established in the European Union is affecting the market there.

“You’ll see a lot more activity in the market in general as a result.”

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

TRADITIONAL HERBS TO SUPPORT BRAIN HEALTH

TRADITIONAL HERBS TO SUPPORT BRAIN HEALTH

SABINSA | 08-Aug-2019 | Technical / White Paper

This white paper discusses traditional plants in Ayurveda which have been used to support cognitive function and memory, and their active phytochemicals....

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars